Company Overview - NeurAxis, Inc. is a medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in both children and adults [3] - The company is advancing its proprietary IB-Stim™ therapy, which utilizes Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, and is FDA cleared for treating functional abdominal pain associated with irritable bowel syndrome (IBS) in adolescents aged 8-21 [3] Upcoming Presentation - NeurAxis will present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025, at 11:00 AM EST, with CEO Brian Carico hosting the presentation [1] - The presentation will be accessible via a webcast, and 1x1 investor meetings can be scheduled during the conference at the Paris Hotel & Casino in Las Vegas, NV [2] Clinical Trials and Development - NeurAxis is conducting additional clinical trials of PENFS for various pediatric and adult conditions that have significant unmet healthcare needs [3]
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025